Recent evidence suggests that neuroinflammation is a key mediator of depression, and, in particular, the expression of pro-inflammatory factors such as NLRP3 and IL-1β is significantly enhanced in depressed patients [111]. Here, NLRP3 is linked to depressive symptom measurement.